Kidney transplantation in emerging countries: do we know all issues?

被引:0
|
作者
Spasovski, G. [1 ]
Vanholder, R. [2 ]
机构
[1] Univ Clin Ctr, Dept Nephrol, Skopje, North Macedonia
[2] Univ Hosp, Nephrol Sect, Ghent, Belgium
关键词
Kidney transplantation; Donor transplantation; Developing countries; RENAL-TRANSPLANTATION; DISEASE; SURVIVAL; DIALYSIS; SPECTRUM; DONATION; BALKANS;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Although it seems that end stage renal disease (ESRD) therapies gradually become more accessible in the developing world, yet, the vast majority of people living in those areas do not have access to dialysis and especially transplantation because of the economic and technological inequality as compared with the developed world. Despite the great advantage in survival and considerable socioeconomic advantages of transplantation vs. dialysis, there is a widespread recognition that the growing gap between organ supply and demand will continue into the foreseeable future. Several reasons might be considered in this regard as: insufficient data on the topic in the public domain, inadequate governmental financial resources, lack of public awareness, education and motivation for organ donation as well as the low number of organized teams of transplant surgeons and nephrologists, and lack of organizational infrastructure, i.e. coordinators. The defined priorities for the future in terms of improving living donor transplantation, composition of the official waiting lists and registries of transplant recipients and living donors and the role of transplant professionals have been discussed. In conclusion, whatever the governmental support is, as professionals, we should just reinforce our efforts to help our patients as best as we can in the current situation.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 50 条
  • [1] What do we know about adenovirus in renal transplantation?
    Florescu, Marius C.
    Miles, Clifford D.
    Florescu, Diana F.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (08) : 2003 - 2010
  • [2] Recurrence of Glomerular Diseases after Kidney Transplantation: What Do We Know New?
    Rodrigo, Emilio
    Belmar, Lara
    Perez-Canga, Jose Luis
    NEPHRON, 2025,
  • [3] Implementing Exercise: What Do We Know? Where Do We Go?
    Painter, Patricia
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2009, 16 (06) : 536 - 544
  • [4] Urban health in developing countries: What do we know and where do we go?
    Harpham, Trudy
    HEALTH & PLACE, 2009, 15 (01) : 107 - 116
  • [5] What do we know about neurogenic bladder prevalence and management in developing countries and emerging regions of the world?
    Przydacz, Mikolaj
    Denys, Pierre
    Corcos, Jacques
    ANNALS OF PHYSICAL AND REHABILITATION MEDICINE, 2017, 60 (05) : 341 - 346
  • [6] What Do We Know about the Patterns and Determinants of Female Entrepreneurship across Countries?
    Minniti, Maria
    Naude, Wim
    EUROPEAN JOURNAL OF DEVELOPMENT RESEARCH, 2010, 22 (03) : 277 - 293
  • [7] Industrial Clusters and Corporate Social Responsibility in Developing Countries: What We Know, What We do not Know, and What We Need to Know
    Peter Lund-Thomsen
    Adam Lindgreen
    Joelle Vanhamme
    Journal of Business Ethics, 2016, 133 : 9 - 24
  • [8] Industrial Clusters and Corporate Social Responsibility in Developing Countries: What We Know, What We do not Know, and What We Need to Know
    Lund-Thomsen, Peter
    Lindgreen, Adam
    Vanhamme, Joelle
    JOURNAL OF BUSINESS ETHICS, 2016, 133 (01) : 9 - 24
  • [9] Emerging role of baricitinib in dermatology practice: All we need to know!
    Dogra, Sunil
    Shah, Shikha
    Sharma, Ayush
    Chhabra, Seema
    Narang, Tarun
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2023, 14 (02) : 153 - 162
  • [10] Autologous and allogeneic mesenchymal stem cells in organ transplantation: what do we know about their safety and efficacy?
    Alagesan, Senthilkumar
    Griffin, Matthew D.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2014, 19 (01) : 65 - 72